Clinical Trial Update: A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase II clinical trial enrolling to evaluate HRS-1893 in non-obstructive hypertrophic cardiomyopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• HRS-1893

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 | Status: RECRUITING